Oxidative stress upregulates PDCD4 expression in patients with gastric cancer via miR-21

Current Pharmaceutical Design

Volumn 20, Issue 11, 2014, Pages 1917-1923

  Tua, Honglei ^a   Sun, Haibing ^a   Lina, Yan ^a   Ding, Jie ^a   Nan, Kejun ^a   Li, Zongfang ^a,b   Shen, Qiang ^c   Wei, Yongchang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Gastric cancer; miR 21; Oxidative stress; Programmed cell death 4

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANINE; ANTIOXIDANT; CATALASE; CELL PROTEIN; DNA GLYCOSYLTRANSFERASE; HUMAN OXOGUANINE GLYCOSYLASE 1; MICRORNA 21; PROGRAMMED CELL DEATH 4 PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TOTAL ANTIOXIDATION COMPETENCE; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; MESSENGER RNA; MICRORNA; MIRN21 MICRORNA, HUMAN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET SPECTROPHOTOMETRY; UPREGULATION; WESTERN BLOTTING; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

AGED; APOPTOSIS REGULATORY PROTEINS; CASE-CONTROL STUDIES; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84903707753     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990547     Document Type: Article

References (58)

1. Farinati F, Piciocchi M, Lavezzo E, et al. Oxidative Stress and Inducible Nitric Oxide Synthase Induction in Carcinogenesis. Digestive Diseases 2010; 28: 579-84.
2. Handa O, Naito Y, Yoshikawa T. Redox biology and gastric carcinogenesis: the role of Helicobacter pylori. Redox Report 2011; 16: 1-7.
3. Ock CY, Hong KS, Kim JH, et al. Free Radicals and Gastric Mucosal Injury. In: Naito Y, Suematsu M, Yoshikawa T, editors. Free Radical Biol Digestive Diseases 2011; p.97-110.
4. Yazicioglu MBI, Gencer S. Differential apoptotic, oxidative stress, and MMP-7 expression response of MKN-45 and 23132/87 gastric carcinoma cell lines to H2O2 exposure. Curr Opinion Biotechnol 2011; 22: S102-S.
5. Bechtel W, Bauer G. Modulation of Intercellular ROS Signaling of Human Tumor Cells. Anticancer Res 2009; 29: 4559-70.
6. Wang S, Wang Q, Wang Y, et al. Novel anthraquinone derivatives: Synthesis via click chemistry approach and their induction of apoptosis in BGC gastric cancer cells via reactive oxygen species(ROS)-dependent mitochondrial pathway. Bioorganic Med Chem Letters 2008; 18: 6505-8.
7. Halbeisen RE, Galgano A, Scherrer T, et al. Post-transcriptional gene regulation: From genome-wide studies to principles. Cellular Mol Life Sci 2008; 65: 798-813.
8. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cellular Mol Med 2009; 13: 39-53.
9. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Ann Rev Med 2009; p. 167-79.
10. Asangani IA, Rasheed SAK, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-36.
11. Frankel LB, Christoffersen NR, Jacobsen A, et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biological Chem 2008; 283: 1026-33.
12. Chan SH, Wu CW, Li AFY, et al. MiR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 2008; 28: 907-11.
13. Ling M, Li Y, Xu Y, et al. Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-kappa B in arsenite-induced cell transformation. Free Radic Biol Med 2012; 52: 1508-18.
14. Allgayer H. Pdcd4. a colon cancer prognostic that is regulated by a microRNA. Critical Rev Oncol Hematol 2010; 73: 185-91.
15. Lankat-BB, Goeke R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 2009; 101: 309-17.
16. Talotta F, Cimmino A, Matarazzo MR, et al. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 2009; 28: 73-84.
17. Jansen AP, Camalier CE, Colburn NH. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 2005; 65: 6034-41.
18. Schmid T, Jansen AP, Baker AR, et al. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res 2008; 68: 1254-60.
19. Leupold JH, Yang HS, Colburn NH, et al. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u- PAR) gene expression via Sp-transcription factors. Oncogene 2007; 26: 4550-62.
20. Hilliard A, Hilliard B, Zheng S-J, et al. Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 2006; 177: 8095-102.
21. Lu Z, Liu M, Stribinskis V, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008; 27: 4373-9.
22. Mudduluru G, Medved F, Grobhoz R, et al. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 2007; 110: 1697-707.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
24. Dincer Y, Akcay T, Tortum OB, et al. Nitric oxide and antioxidant defense in patients with gastric cancer. Digestive Diseases Sci 2006; 51: 1367-70.
25. Rainis T, Maor I, Lanir A, et al. Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon. Digestive Diseases Sci 2007; 52: 526-30.
26. Zhang M, Liu L, Cheng L, et al. Express of plasma ROS, SOD and GSH-PX in patients with nasopharyngeal carcinoma. Lin chuang er bi yan hou ke za zhi = J Clin Otorhinolaryngol 2003; 17: 650-1.
27. Smith PS, Zhao W, Robbins M. Knocking down catalase leads to increased ROS production and proliferation in glioma cells. Proc Am Assoc Cancer Res Ann Meeting 2006; 47: 1037
28. Vandenbranden C, Peeters P, Vandenhoute K, et al. Catalase activity and ros production in rat remnant kidney - effect of enalapril (E) and vitamin-E (VIT-E). J Am Soc Nephrol 1995; 6: 1033
29. Hwang E-S, Kim G-H. Biomarkers for oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research (Retracted article. See vol 241, pg 98, 2007). Toxicology 2007; 229: 1-10.
30. Komatsu T, Sasahara A, Maehata Y, et al. Oxidative stress marker 8-hydroxy-2 '-deoxyguanosine (8-OHdG) and periodontitis in saliva. Ann Nutrition Metabol 2008; 53: 63
31. Morishita Y, Hanawa S, Miki T, et al. The association of plasma prorenin level with an oxidative stress marker, 8-OHdG, in nondiabetic hemodialysis patients. Clin Exp Nephrol 2011; 15: 398-404.
32. Nakajima H, Unoda KI, Ito T, et al. The Relation of Urinary 8- OHdG, A Marker of Oxidative Stress to DNA, and Clinical Outcomes for Ischemic Stroke. Open Neurol J 2012; 6: 51-7.
33. Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2' - deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis. J Environmental Sci Health Part CEnvironmental Carcinogenesis Ecotoxicol Rev 2009; 27: 120-39.
34. Prabhulkar S, Li CZ. Assessment of oxidative DNA damage and repair at single cellular level via real-time monitoring of 8-OHdG biomarker. Biosensors Bioelectronics 2010; 26: 1743-9.
35. Karahalil B, Emerce E, Kocer B, et al. The association of ogg1 ser326cys polym orphism and urinary 8-ohdg levels with lung cancer suscepti bility: a hospital-based case-control study in turkey. Arhiv Za Higijenu Rada I Toksikologiju 2008; 59: 241-50.
36. Karahalil B, Kesimci E, Emerce E, et al. The impact of OGG1, MTH1 and MnSOD gene polymorphisms on 8-hydroxy-2 '- deoxyguanosine and cellular superoxide dismutase activity in myocardial ischemia-reperfusion. Mol Biol Rep 2011; 38: 2427-35.
37. Kondo S, Toyokuni S, Tanaka T, et al. Overexpression of the hOGG1 gene and high 8-hydroxy-2 '-deoxyguanosine (8-OHdG) lyase activity in human colorectal carcinoma: Regulation mechanism of the 8-OHdG level in DNA. Clinl Cancer Res 2000; 6: 1394-400.
38. Ni J, Mei M, Sun L. Oxidative DNA Damage and Repair in Chronic Atrophic Gastritis and Gastric Cancer. Hepato- Gastroenterol 2012; 59: 671-5.
39. Goldring MB, Marcu KB. Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis. Trends Mol Med 2012; 18: 109-18.
40. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. Embo Mol Med 2012; 4: 143-59.
41. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc tl Acad Sci USA 2006; 103: 2257-61.
42. Cao Z, Yoon JH, Nam SW, et al. PDCD4 expression inversely correlated with miR-21 levels in gastric cancers. J Cancer Res Clinl Oncol 2012; 138: 611-9.
43. Yu XC, Song HJ, Guo JM. MicroRNAs Involved in Metastasis of Gastric Cancer. Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao 2011; 27: 907-13.
44. Zhang Z, Li Z, Gao C, et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Laboratory Investigation 2008; 88: 1358-66.
45. Zheng Y, Cui L, Sun W, et al. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer biomarkers: section A of Disease Markers 2011; 10: 71-7.
46. Cheng Y, Liu X, Zhang S, et al. MicroRNA-21 protects against the H2O2-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cellular Cardiol 2009; 47: 5-14.
47. Ab Mutalib NS, Yoke KC, Rahman SA, et al. Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. Int J Mol Med 2011; 28: 327-36.
48. Simone NL, Soule BP, Ly D, et al. Ionizing radiation-induced oxidative stress alters miRNA expression. Plos One 2009; 4: e6377.
49. Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptio nally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-36.
50. Lu Z, Liu M, Stribinskis V, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008; 27: 4373-9.
51. Zhu S, Wu H, Wu F, et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008; 18: 350-9.
52. Yamamichi N, Shimomura R, Inada K, et al. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clinical cancer research: an official J Am Assoc Cancer Res 2009; 15: 4009-16.
53. Gaur AB, Holbeck SL, Colburn NH, et al. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro-Oncology 2011; 13: 580-90.
54. Peacock O, Lee A, Cameron F, et al. The role of MiR-21 and Pdcd4 in colorectal cancer. Br J Surgery 2012; 99: 24
55. Cmarik JL, Min H, Hegamyer G, et al. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 1999; 96: 14037-42.
56. Jansen AP, Camalier CE, Colburn NH. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 2005; 65: 6034-41.
57. Chen Y, Knosel T, Kristiansen G, et al. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 2003; 200: 640-6.
58. Mudduluru G, Medved F, Grobholz R, et al. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 2007; 110: 1697-707.